Huahai Vitiligo Hospital Director Cheng Aihua to lead academic exchanges during trip to Africa and the Middle East this month.
(PRWEB) March 05, 2016
In response to the implementation of Chinese President Xi Jinping’s Belt and Road Initiative, Huahai Vitiligo Hospital is proud to announce an upcoming trip to Africa and the Middle East to promote China-Africa academic exchanges and cooperation in vitiligo research. The famous Chinese vitiligo expert Cheng Aihua has been invited to Ghana, Kenya and Dubai for academic study and exchanges in early March 2016.
Aihua, director of the Huahai Vitiligo Hospital, is the expert of the United Nations vitiligo research clinic demonstration base. She has researched vitiligo for more than 23 years and developed a new vitiligo treatment, BWCT(black and white cured together). BWCT is now one of the world’s leading vitiligo treatments. This technology is the first vitiligo technology led by government. BWCT can treat all patients, regardless of the patient’s age, vitiligo size, or history of vitiligo. The new vitiligo treatment has successfully treated hundreds of thousands of patients from 118 countries worldwide. Aihua has been called the first person to cure vitiligo.
During her visit to Ghana, Kenya and Dubai, Aihua will conduct extensive exchanges with local government health officials and academic authorities. At the same time, to promote cooperation in the field of vitiligo medicine, she will also help people who want to engage in the medical field of vitiligo research to achieve entrepreneurial dreams. The “Internet + traditional Chinese medicine treatment” project will use remote diagnosis over the internet and scientific treatment for patients.
About Huahai Vitiligo Hospital
Huahai Vitiligo Hospital has specialized in the treatment of vitiligo for 20 years. They have the largest vitiligo research laboratory and preparation center in China and have taken China’s National Ministry of Science and Technology to new heights regarding researching vitiligo. They have obtained more than 20 national patents and the protection of non-material cultural heritage. They have performed research of vitiligo therapeutic treatments and 13 medical monographs. In addition they have been published in Vitiligo Thoughts as well as more than 300 academic journals both at home and abroad. For more information visit http://www.hhvitiligo.com/.
For the original version on PRWeb visit: http://www.prweb.com/releases/2016/03/prweb13244000.htm